These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38677652)

  • 1. Calcineurin inhibitor toxicity in de novo thrombotic microangiopathy-Is the culprit what we think it is?
    Petr V; Zahradka I; Viklicky O
    Am J Transplant; 2024 Sep; 24(9):1708-1709. PubMed ID: 38677652
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus-induced thrombotic microangiopathy: natural history of a severe, acute vasculopathy.
    Carson JM; Newman ED; Farber JL; Filippone EJ
    Clin Nephrol; 2012 Jan; 77(1):79-84. PubMed ID: 22185974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus.
    Cortina G; Trojer R; Waldegger S; Schneeberger S; Gut N; Hofer J
    Pediatr Nephrol; 2015 Apr; 30(4):693-7. PubMed ID: 25577332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report.
    Safa K; Logan MS; Batal I; Gabardi S; Rennke HG; Abdi R
    Clin Nephrol; 2015 Feb; 83(2):125-9. PubMed ID: 24495904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation.
    Takeda A; Ohtsuka Y; Horike K; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():15-8. PubMed ID: 21623908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De Novo Thrombotic Microangiopathy Immediately After Kidney Transplant in Patients Without Apparent Risk Factors.
    Patel A; Knorr JP; Campos S; Khanmoradi K; Zaki RF; Bradauskaite G
    Exp Clin Transplant; 2016 Apr; 14(2):230-4. PubMed ID: 26030297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intestinal thrombotic microangiopathy after liver transplantation].
    Kim ER; Kim KM
    Korean J Gastroenterol; 2011 Mar; 57(3):198-200. PubMed ID: 21519170
    [No Abstract]   [Full Text] [Related]  

  • 8. Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report.
    Merola J; Yoo PS; Schaub J; Smith JD; Rodriguez-Davalos MI; Tichy E; Mulligan DC; Asch W; Formica R; Kashgarian M; Kulkarni S
    Transplant Proc; 2016 Nov; 48(9):3106-3108. PubMed ID: 27932157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living-Donor Kidney Transplant-Associated Thrombotic Microangiopathy Successfully Treated With Thymoglobulin: A Case Report.
    Akl A; Alobaidi S; Aboalsamh G
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):175-177. PubMed ID: 30777549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathy in a renal allograft: Single-center five-year experience.
    Vanikar AV; Kanodia KV; Suthar KS; Nigam LA; Patel RD; Thakkar UG; Mehta AH
    Saudi J Kidney Dis Transpl; 2020; 31(6):1331-1343. PubMed ID: 33565445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.
    Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B
    Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy associated with tacrolimus in lung transplantation.
    Reig Mezquida JP; Jover AS; Ansótegui Barrera E; Escrivá Peiró J; Pastor Colom MD; Pastor Guillem J
    Arch Bronconeumol; 2015 May; 51(5):e23-4. PubMed ID: 25138798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-related systemic thrombotic microangiopathy after renal transplantation.
    Negrini S; Durrbach A; Becquemont L
    Therapie; 2014; 69(2):175-7. PubMed ID: 24926637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy.
    Gabr JB; Bilal H; Mirchia K; Perl A
    J Investig Med High Impact Case Rep; 2020; 8():2324709620947266. PubMed ID: 32757799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported Cause.
    Sala E; Neagoie AM; Lewerenz J; Saadati M; Benner A; Gantner A; Wais V; Döhner H; Bunjes D
    Transplant Cell Ther; 2024 Jun; 30(6):586.e1-586.e11. PubMed ID: 38508452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab.
    Morales E; Rabasco C; Gutierrez E; Praga M
    Transpl Int; 2015 Jul; 28(7):878-80. PubMed ID: 25712140
    [No Abstract]   [Full Text] [Related]  

  • 18. De novo thrombotic microangiopathy after kidney transplantation in adults: Interplay between complement genetics and multiple endothelial injury.
    Dessaix K; Bontoux C; Aubert O; Grünenwald A; Sberro Soussan R; Zuber J; Duong Van Huyen JP; Anglicheau D; Legendre C; Fremeaux Bacchi V; Rabant M
    Am J Transplant; 2024 Jul; 24(7):1205-1217. PubMed ID: 38320731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus/sirolimus: a call for use of consensus definition in reporting.
    Kharfan-Dabaja MA; Pidala J; Anasetti C
    Blood; 2010 May; 115(21):4316-7; author reply 4317. PubMed ID: 20508174
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.
    Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Yoshida Y; Ikeda M; Ishikawa S; Narita I; Takahashi K; Tomita Y
    Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.